Magnetic Resonance Imaging (MRI)
[Cancer Control] This research examines cardio-oncology programs and their role in the multidisciplinary approach to cancer care.
MRI screening has high specificity and positive predictive value in average risk women.
Magnetic resonance imaging and MRI-targeted biopsy can facilitate detection of clinically significant prostate disease.
Study data presented at SABCS 2016 indicates that preoperative MRI is effective for detecting mammographically occult, early-stage, hormone receptor (HR)-positive contralateral breast cancer (CBC) in older patients.
Consensus statement presents guidelines for prostate magnetic resonance imaging (MRI) in patients with negative biopsy.
Employing a prone position during preoperative breast magnetic resonance imaging might introduce error.
Internal mammary lymph nodes (IMLNs) identified at implant-protocol breast magnetic resonance imaging (MRI) are more likely to be benign than malignant.
An eight-fold increase in preoperative breast MRI was seen over a 10-year period; MRI use was linked to more ancillary investigations.
Scientists have discovered that magnetic resonance imaging (MRI) scanners, normally used to produce images, can be used direct tumor therapies to specific target sites.
With the availability of tomosynthesis mammography, should women at high risk for developing breast cancer still undergo annual MRI?
Breast screening via ultrasound is unaffected by breast density, is not associated with ionizing radiation, and does not require IV contrast material, but acceptance of this modality has lagged.
Targeted magnetic resonance (MR)/ultrasound fusion biopsy outperformed standard biopsy technique for increased detection of high-risk prostate cancer, according to a recent study.
Magnetic resonance imaging (MRI) is gold standard for imaging axial skeleton, assessing painful lesions, and identification of benign fractures.
A research team has created a new, self-assembling nanoparticle that can increase the effectiveness of magnetic resonance imaging (MRI) cancer detection.
Initial results indicate that annual magnetic resonance imaging (MRI) and digital mammography can form an effective screening program for women at high risk of breast cancer, according to research.
When women undergo MRIs to check for breast cancer, the scans sometimes reveal suspicious masses elsewhere in the body, which can generate a lot of anxiety and require more testing.
The largest clinical study to evaluate breast cancer screening of female survivors of childhood Hodgkin lymphoma, showed that MRI detected invasive breast tumors at very early stages, when cure rates are expected to be excellent.
Multiparametric MRI is highly accurate for the detection of prostate cancer in patients with clinically low-risk cancer; accuracy is highest with larger cancer volume and higher Gleason grade.
In a series of studies involving Americans with liver tumors, researchers used specialized three-dimensional MRI scans to precisely measure whether highly toxic chemotherapy is working.
A new type of magnetic resonance imaging (MRI) scan, known as diffusion-weighted MRI, could improve care for myeloma and reduce reliance on bone marrow biopsies.
Drastic reimbursement cuts for image-guided breast biopsies, and other medical imaging techniques in the 2014 Medicare Fee Schedule Final Rule, may further reduce women's access to mammography and other breast cancer services.
A large national study has found that the rate of women undergoing magnetic resonance imaging (MRI) of the breast nearly tripled from 2005 to 2009: from four to 11 examinations per 1,000 women.
Two studies show increases in MRI use; few meet criteria of American Cancer Society for screening.
A new way of analyzing data acquired in magnetic resonance imaging appears to identify whether or not tumors are responding to anti-angiogenesis therapy.
No significant difference in five-, eight-year locoregional recurrence rates with, without MRI
There has been increasing incidence of small and indolent thyroid cancer but mortality rate has been stable since 1979.
Heavy use of magnetic resonance imaging (MRI) may be leading to unnecessary breast removal in older women with breast cancer, according to a new study.
A clinic-based technique of targeted biopsy using MRI and ultrasound may improve the diagnosis and management of prostate cancer.
Imaging with 18F-FLT positron emission tomography provides tumor-specific details accurately and noninvasively in persons with gliomas.
Assessing how water moves through breast tissue may reduce false-positive findings among women undergoing dynamic contrast-enhanced MRI.
Sign Up for Free e-newsletters
- Resolving Vaginal Dryness in Women With a History of Breast Cancer
- FDA Issues Warning for Rolapitant Injectable Emulsion in the Treatment of CINV
- Risk Factors for Arterial, Venous Thrombosis Differ in Polycythemia Vera
- Distinct Patterns of Shiny White Streaks Strong Indicator of Melanoma
- Survival Outcomes in Relapsed Hepatocellular Carcinoma Improved With Cabozantinib
- Pertuzumab Regimen Approved for Adjuvant, Neoadjuvant Therapy in Specific Breast Cancers
- Common Oncologic Emergencies That Occur With Multiple Myeloma
- Artificial Sweeteners and Cancer Risk (Fact Sheet)
- Blueberry Extract May Boost Efficacy of Radiotherapy for Cervical Cancer
- Dietary Estrogens Reduced Efficacy of Novel Breast Cancer Therapy
- When There Are No Words: Interpreting Patients' and Families' Subtle Messages
- Depression Predictive of Poor Survival Outcomes in Head and Neck Cancer
- Nearly One Third of Veterans Report Current Tobacco Use
- Priority Review of New Drug Application Granted to Apalutamide for CRPC
- Partial Response Achieved With Atezolizumab, Cobimetinib in Pretreated CRC
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|